People with FASD, lived experience with FASD, and caregivers of people with FASD can now apply for financial support to attend the Canada FASD Conference this November.
New Issue Paper: Neurodiversity and FASD
Neurodiversity may be a complex concept, but at the core, individuals should be appreciated for who they are, differences and all.
Top FASD Articles of 2022 Announced
Without further ado, here are the top FASD research articles of 2022!
Celebrating Strengths in FASD this Neurodiversity Week
Its Neurodiversity Celebration Week! We had the opportunity to sit down with Dr. Katy Flannigan to talk about a new study we’re doing on strengths in adults with fetal alcohol spectrum disorder (FASD). Here are a few highlights from that conversation.
Announcing the 2023 Dr. Sterling Clarren Research Award Recipient!
We are pleased to announce the recipient of the 2023 Dr. Sterling Clarren FASD Research Award is Danielle Johnston for her research on visual-motor integration, visual perception and motor coordination assessments in children with FASD.
New Course on Substance Use Treatment and FASD
Substance Use and Treatment in FASD is a Level II online training course designed to support substance use and addictions professionals when treating individuals with FASD.
Registration Open for Canada FASD Conference!
You can now register for the Canada FASD Conference, happening November 7-9, 2023, in Saskatoon, Saskatchewan!
New Webinar: Correctional Services and FASD
Join us for our newest webinar, A Conversation About Correctional Services and FASD, happening Friday, February 24 at 1:00pm EST.
Abstract Submission Open for the Canada FASD Conference!
We are pleased to announce that we are now accepting abstract submissions for the Canada FASD Conference!
New Issue Paper: Diagnostic Assessment of Preschoolers
It is well established that early interventions and diagnosis are critical to supporting healthy outcomes in the future. However, there is a limited body of research focused on FASD diagnosis in preschool aged children and a reluctance among clinicians to provide a definitive diagnosis at this age.